Acasti is a late-stage specialty pharma company with drug delivery capability and technologies addressing rare and orphan diseases. The Company’s novel drug delivery technologies have the potential to improve the performance of currently marketed drugs by achieving faster onset of action, enhanced efficacy, reduced side effects, and more convenient drug delivery – all which could help to increase treatment compliance and improve patient outcomes. The Company is focused on well-understood diseases that are poorly served by available therapies or have no approved therapies. Acasti is initially targeting three underserved orphan diseases - Subarachnoid Hemorrhage (SAH), Ataxia Telangiectasia (A-T), and Postherpetic Neuralgia (PHN) – all with sizable patient populations and significant market opportunity. The Company’s three lead clinical assets have all been granted Orphan Drug Designation by the FDA providing seven years of marketing exclusivity post-launch in the United States and are protected by over 40 granted and pending patents.
View Top Employees from Acasti Pharma Inc.Website | https://www.acasti.com/en |
Ticker | ACST |
Revenue | $10 million |
Employees | 27 (27 on RocketReach) |
Founded | 2002 |
Address | 3009, boul. de la Concorde E., Suite 102, Laval, Quebec H7E 2B5, CA |
Phone | (450) 686-4555 |
Fax | (450) 686-2505 |
Industry | Biotechnology Research, Pharmaceuticals, Healthcare |
Web Rank | 10 Million |
Keywords | Acasti Pharma, Acasti Pharma News, Acasti Pharma Sherbrooke, Acasti, Acasti Cash |
SIC | SIC Code 28 Companies, SIC Code 283 Companies |
NAICS | NAICS Code 32541 Companies, NAICS Code 32 Companies, NAICS Code 3254 Companies, NAICS Code 325 Companies |
Looking for a particular Acasti Pharma Inc. employee's phone or email?
The Acasti Pharma Inc. annual revenue was $10 million in 2024.
Prashant Kohli is the Chief Commercial Officer of Acasti Pharma Inc..
27 people are employed at Acasti Pharma Inc..
Acasti Pharma Inc. is based in Laval, Quebec.
The NAICS codes for Acasti Pharma Inc. are [32541, 32, 3254, 325].
The SIC codes for Acasti Pharma Inc. are [28, 283].